ConductScience.org, home

Paper39425201

Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.

Marín-Cerezuela M and 8 others. Crit Care, 2024. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support. Papers, record 39425201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39425201

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.
PubMed
Journal
Crit Care
PubMed
Year
2024
PubMed
Publication types
Letter
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.05, provisional
iCite
Revised in PubMed
2024-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marín-Cerezuela MMaría
2Martín-Latorre RRuben
3Frasquet JJuan
4Ruiz-Ramos JJesus
5Garcia-Contreras SSandra
6Gordón MMónica
7Broch MJMaría Jesús
8Castellanos-Ortega ÁÁlvaro
9Ramirez PPaulahttps://orcid.org/0000-0002-7598-3350

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138,667,049No Sequestration of Commonly Used Anti-Infectives in the Extracorporeal Membrane Oxygenation (ECMO) Circuit-An Ex Vivo Study.Antibiotics (Basel)2024https://conductscience.org/library/papers/38667049PubMed
234,250,190Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration.Open Forum Infect Dis2021https://conductscience.org/library/papers/34250190PubMed
337,351,777Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit.Eur J Drug Metab Pharmacokinet2023https://conductscience.org/library/papers/37351777PubMed
422,722,776Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.Ther Drug Monit2012https://conductscience.org/library/papers/22722776PubMed
529,311,072Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29311072PubMed
634,071,700Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance.Antibiotics (Basel)2021https://conductscience.org/library/papers/34071700PubMed
733,677,539An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients.J Antimicrob Chemother2021https://conductscience.org/library/papers/33677539PubMed
831,724,042Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin.Clin Infect Dis2019https://conductscience.org/library/papers/31724042PubMed
936,853,601Pharmacokinetics of cefiderocol during extracorporeal membrane oxygenation: A case report.Perfusion2023https://conductscience.org/library/papers/36853601PubMed
1036,498,473
Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation.
J Clin Med2022https://conductscience.org/library/papers/36498473PubMed
1134,383,901Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.J Antimicrob Chemother2021https://conductscience.org/library/papers/34383901PubMed
1236,215,036Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.Am J Respir Crit Care Med2023https://conductscience.org/library/papers/36215036PubMed
1334,710,630
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol.
J Glob Antimicrob Resist2021https://conductscience.org/library/papers/34710630PubMed
1433,257,454
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.
Antimicrob Agents Chemother2021https://conductscience.org/library/papers/33257454PubMed
1537,192,727
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF).
Int J Antimicrob Agents2023https://conductscience.org/library/papers/37192727PubMed
1638,442,737Nosocomial Infections in Adults Receiving Extracorporeal Membrane Oxygenation: A Review for Infectious Diseases Clinicians.Clin Infect Dis2024https://conductscience.org/library/papers/38442737PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41,375,718The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review.J Clin Med2025https://conductscience.org/library/papers/41375718PubMed
41,303,095Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo Experiments.J Clin Med2025https://conductscience.org/library/papers/41303095PubMed
40,145,524Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024.Rev Esp Quimioter2025https://conductscience.org/library/papers/40145524PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39425201

GET https://conductscience.org/api/papers/v1/39425201/authors